Table 1: Clinical characteristics of the study population.
|
Total (N = 110) |
≤ 50 years (N = 25) |
> 50 years (N = 85) |
P value |
Age (years) |
59 ± 12 |
41 ± 6.49 |
64 ± 8 |
|
Gender |
||||
Male (N,%) |
78 (71%) |
19 (76%) |
59 (69%) |
0.356 |
Female (N,%) |
32 (29%) |
6 (24%) |
26 (31%) |
|
Risk factors |
||||
Hypertension |
70 (64%) |
10 (40%) |
60 (71%) |
0.006 |
Diabetes |
34 (31%) |
7 (28%) |
27 (32%) |
0.462 |
Smoking |
31 (28%) |
14 (56%) |
17 (20%) |
0.001 |
Renal disease |
15 (14%) |
3 (12%) |
12 (14%) |
0.542 |
Alcohol |
7 (6%) |
5 (20%) |
2 (2%) |
0.006 |
Drug abuse |
5 (5%) |
4 (16%) |
1(1%) |
0.002 |
APT |
17 (15%) |
1 (4%) |
16 (19%) |
0.059 |
ACT |
7 (6%) |
0 (0%) |
7 (8%) |
0.155 |
GCS |
||||
Grade I |
39 (35%) |
10 (40%) |
29 (34%) |
0.754 |
Grade II |
29 (26%) |
6 (24%) |
23 (27%) |
|
Grade III |
22 (20%) |
6 (24%) |
16 (18.8%) |
|
Grade IV |
20 (18%) |
3 (12%) |
17 (20%) |
|
APC: Antiplatelet Therapy; ACP: Anticoagulants Therapy